Esthesioneuroblastoma epidemiology and demographics
|
Esthesioneuroblastoma Microchapters | |
|
Diagnosis | |
|---|---|
|
Treatment | |
|
Case Studies | |
|
Esthesioneuroblastoma epidemiology and demographics On the Web | |
|
American Roentgen Ray Society Images of Esthesioneuroblastoma epidemiology and demographics | |
|
Esthesioneuroblastoma epidemiology and demographics in the news | |
|
Blogs on Esthesioneuroblastoma epidemiology and demographics | |
|
Risk calculators and risk factors for Esthesioneuroblastoma epidemiology and demographics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]
Epidemiology and Demographics
Esthesioneuroblastoma accounts for approximately 5 % of all sinonasal tumors.
Incidence
The incidence of esthesioneuroblastoma was estimated to be 0.4 cases per 100,000 individuals worldwide.
Prevalence
Age
Esthesioneuroblastoma commonly affects individuals in a wide range of age groups younger than 90/older than 3 (3-90) years of age. There exists a bimodal peak of occurrence in the third and sixth decades of life. The majority of cases of esthesioneuroblastoma occur in patients between 40 and 70 years of age; the median age at diagnosis is 53 years.
Race
There is no racial predilection to the esthesioneuroblastoma.
Gender
Esthesioneuroblastoma affects men and women equally. There was a moderate male predominance with a 55:45 male:female ratio. Males are more commonly affected with esthesioneuroblastoma than females. The male to female ratio is approximately [1.2 > 1] to 1.